Navigation Links
Cardinal Health Specialty Solutions Submits 1,000th Electronic Common Technical Document (eCTD) to FDA
Date:3/21/2012

DUBLIN, Ohio, March 21, 2012 /PRNewswire/ -- The Scientific and Regulatory Consulting Services business of Cardinal Health Specialty Solutions, previously known as Beckloff Associates, announced today that over the past five years it has submitted 1,000 electronic Common Technical Documents (eCTDs) to the U.S. Food and Drug Administration (FDA) on behalf of more than 200 clients, worldwide.

Since its introduction in 2003, the eCTD has rapidly become the format of choice for drug and biologic applications, including New Drug Applications (NDAs) and Abbreviated New Drug Applications (ANDAs) reviewed by FDA; and for marketing applications reviewed by other global health authorities. eCTDs help accelerate the approval process for bringing new pharmaceutical products to market, and can improve the overall costs of drug development.

"For more than 35 years, we have been helping pharmaceutical and biotech companies speed product development, approval and post-approval," said Michael Beckloff, vice president and general manager, Scientific and Regulatory Consulting Services for Cardinal Health Specialty Solutions. "Reaching this milestone – publishing 1,000 eCTDs – demonstrates our proven success in delivering high-value regulatory publishing and consulting services to clients with drug and biologic products at all stages of development and approval."

According to Beckloff, Cardinal Health Specialty Solutions' extensive team of veteran scientific and regulatory consultants and publishing professionals, its ability to operate multiple eCTD publishing hardware and software platforms and its adaptability are three of the main strengths that have enabled his team to reach this milestone. The team's approach eliminates the need for software and hardware investment and provides immediate, flexible and responsive publishing capacity.

"Cardinal Health Specialty Solutions has provided publishing and critical scientific and regulatory work for our NDA, from the original submission in late 2010 through approval, and now they're also supporting our post-approval submissions," said Douglas Saltel, president and CEO of Edgemont  Pharmaceuticals. "We have placed a great deal of trust in them and they continue to deliver the right solutions for us."

Cardinal Health Specialty Solutions partners with each client to understand their desired regulatory outcomes, and then applies its expert knowledge to reach those outcomes, enabling clients to focus their time and attention on other critical aspects of the approval process.

"From the publishing of our original Investigational New Drug (IND) in 2010, through many IND amendments, and in the planning and preparation of our NDA submission, we have tested Cardinal Health Specialty Solutions' ability to accommodate tight timeframes and to respond to our business priorities," said Jerry Wisler, CEO of Omthera Pharmaceuticals. "They have consistently published with efficiency and without quality compromises."

About Cardinal Health Specialty Solutions

Cardinal Health Specialty Solutions provides regulatory, clinical, reimbursement, technology and distribution services to help health care professionals, payors and pharmaceutical and biotech companies improve the quality and cost-effectiveness of caring for patients who are managing complex diseases.  Cardinal Health Specialty Solutions partners with customers to alleviate day-to-day administrative burdens, optimize business functions and to implement new innovations that move their businesses forward.  To learn more, visit www.cardinalhealth.com/specialtysolutions.

About Cardinal Health

Headquartered in Dublin, Ohio, Cardinal Health, Inc. (NYSE: CAH) is a $103 billion health care services company that improves the cost-effectiveness of health care. As the business behind health care, Cardinal Health helps pharmacies, hospitals, ambulatory surgery centers and physician offices focus on patient care while  reducing costs, enhancing efficiency and improving quality. Cardinal Health is an essential link in the health care supply chain, providing pharmaceuticals and medical products to more than 60,000 locations each day. The company is also a leading manufacturer of medical and surgical products, including gloves, surgical apparel and fluid management products. In addition, the company supports the growing diagnostic industry by supplying medical products to clinical laboratories and operating the nation's largest network of radiopharmacies that dispense products to aid in the early diagnosis and treatment of disease. Ranked #19 on the Fortune 500, Cardinal Health employs more than 30,000 people worldwide. More information about the company may be found at cardinalhealth.com and @CardinalHealth on Twitter.


'/>"/>
SOURCE Cardinal Health
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Cardinal Health Releases New Tool to Combat MRSA Infections in Hospitals
2. Stem Cell Breakthrough Advances Science Without Ethical Landmines, Says Cardinal
3. Hydrox Inc., Cardinal Health Issue Nationwide Recall of Alcohol-Free Mouthwash For Hospitals
4. Cardinal Health Completes Enturia Acquisition
5. Cardinal Health Expands PET Nuclear Pharmacy Services to Support Clinical Drug Trials
6. AmeriCares Honors Cardinal Health with Power of Partnership Award
7. Cardinal Health Helps Hospitals Save More Than $20 Million In Pharmaceutical Costs; Connect Low-Income Patients With Affordable Medications
8. Cardinal Health Executives to Speak at Two Investor Events in January
9. Cardinal Health Names Carrie Cox to Board of Directors
10. Cardinal Health Raises Quarterly Dividend By 11 Percent
11. Cardinal Health Supports ACRIN Clinical Trials Evaluating Oncologic Biotracers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... , Feb. 9, 2016 On ... Administration (FDA) met with its Arthritis Advisory ... biosimilar of Johnson & Johnson,s Remicade and ... approved in the U.S. The Biologics Prescribers ... groups - Alliance for Patient Access, American ...
(Date:2/10/2016)... February 10, 2016 Demonstrates ... 1 receptor selectivity   1 ... which has entered clinical development as a new ... and schizophrenia.   --> 1 ... has entered clinical development as a new treatment ...
(Date:2/9/2016)... 9, 2016  Insulet Corporation (NASDAQ: PODD ) (Insulet ... technology with its OmniPod ® Insulin ... has been appointed to Insulet,s Board of Directors. With his ... of whom are independent. --> ... and finance experience and a deep knowledge of accounting, financial ...
Breaking Medicine Technology:
(Date:2/10/2016)... La Puente, California (PRWEB) , ... February 09, ... ... Dental Medicine students, faculty and staff helped give free oral screenings to 150 ... California Feb. 5, 2016. , The College of Dental Medicine joined Chinese American ...
(Date:2/9/2016)... Fort Lauderdale, Florida (PRWEB) , ... February 09, 2016 , ... ... known as the Taste of South Florida Event, an upscale fundraiser held in South ... to wow sponsors and guests alike. This year the event will be held in ...
(Date:2/9/2016)... ... February 09, 2016 , ... A new study ... rates and Medicare rates for a variety of medical services in Illinois as ... of the 2015 Fee Schedule Rates in Illinois, are professional medical services, ...
(Date:2/9/2016)... ... , ... On January 12, 2016 Paul McElwee, a CroppMetcalfe HVAC technician, visited ... not producing any heat. Shortly after entering the home, Paul was able to identify ... levels of carbon monoxide into the home, at 2,000 parts per million in the ...
(Date:2/9/2016)... , ... February 09, 2016 , ... ... The guide will ensure lab personnel have a basic understanding of the techniques ... measurement protocols. Enhanced understanding will help them reduce waste and rework to create ...
Breaking Medicine News(10 mins):